ClinicalTrials.Veeva

Menu

Clinical Evaluation of Efficacy and Stability of AT TORBI 709M 4-haptic Toric IOL in Cataract Surgery

Seoul National University logo

Seoul National University

Status

Unknown

Conditions

Iol
Astigmatism

Treatments

Procedure: AT TORBI 709M

Study type

Interventional

Funder types

Other

Identifiers

NCT02618018
AT TORBI 709M toric IOL

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and stability of AT TORBI 709M 4-haptic toric IOL in cataract surgery.

Full description

Inclusion criteria

  1. senile cataract
  2. patients' age of 21 years or older
  3. preoperative regular corneal astigmatism between 1.00 D and 6.00 D

Exclusion criteria

  1. pregnant, lactating women
  2. presence of other ocular diseases which affect stability of lens capsule

Primary outcome : efficacy index (visual acuity, refractive results Secondary outcome : rotational stability, endothelial cell count, cornea thickness

Enrollment

20 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • senile cataract
  • patients' age of 21 years or older
  • preoperative regular corneal astigmatism between 1.00 D and 6.00 D

Exclusion criteria

  • pregnant, lactating women
  • presence of other ocular diseases which affect stability of lens capsule

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

intraocular lens
Experimental group
Description:
AT TORBI 709M toric intraocular lens
Treatment:
Procedure: AT TORBI 709M

Trial contacts and locations

1

Loading...

Central trial contact

Yu Jeong Kim, MD; Mee Kum Kim, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems